Xylos Arteriors India Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 9.94 Cr
as on 03-07-2024
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 87.70%
(FY 2023)
- Profit 558.60%
(FY 2023)
- Ebitda 487.69%
(FY 2023)
- Net Worth 36.95%
(FY 2023)
- Total Assets 56.99%
(FY 2023)
About Xylos Arteriors India
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chieng Ung, Pardeep Singh, and Shah Ramesh serve as directors at the Company.
- CIN/LLPIN
U51101MH2009FTC285179
- Company No.
285179
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
31 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Xylos Arteriors India Private Limited offer?
Xylos Arteriors India Private Limited offers a wide range of products and services, including Hardwood Flooring & Wooden Floor Tiles, Hardwood Flooring, Deck Flooring, Laminate Floorings, Wooden Flooring.
Who are the key members and board of directors at Xylos Arteriors India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chieng Ung  | Additional Director | 25-Jul-2018 | Current |
| Pardeep Singh | Additional Director | 25-Jul-2018 | Current |
Shah Ramesh  | Director | 01-Oct-2013 | Current |
Financial Performance of Xylos Arteriors India.
Xylos Arteriors India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.7% increase. The company also saw a substantial improvement in profitability, with a 558.6% increase in profit. The company's net worth Soared by an impressive increase of 36.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xylos Arteriors India?
In 2023, Xylos Arteriors India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xylos Arteriors India?
Xylos Arteriors India has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xylos Arteriors India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xylos Arteriors India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
